跳至主要内容
临床试验/NCT03306251
NCT03306251Unknown不适用

ANRS CO11 : National Cohort of Children Born to HIV-positive Mothers

ANRS, Emerging Infectious Diseases45 个研究点 分布在 4 个国家目标入组 5,200 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
5,200
试验地点
45
主要终点
Efficacy of PMTCT strategies by measuring rate of mother to child transmission of HIV

研究概览

简要总结

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

详细描述

The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to monitor changes in the rate of mother to child transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1 maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM).

Maternal clinical, biological and therapeutic data before and during pregnancy were collected at delivery, with simplified questionnaires.

The children are examined clinically and biologically at birth, 6, 12 and 24 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women >= 18 years
  • infected with HIV1 and/or HIV2

排除标准

  • guardianship or judicial or administrative detention

结局指标

主要结局

Efficacy of PMTCT strategies by measuring rate of mother to child transmission of HIV

时间窗: At birth up to 24 months

Number of infected children (HIV RNA \>50c/mL or Positive serology) reported on the total number of children

次要结局

  • Immuno-virological response during pregnancy(At inclusion up to childbirth)
  • Impact of different kind of MTCT prophylaxis on childbirth(At delivery)
  • Tolerance and toxicity of different kind of MTCT prophylaxis during pregnancy(At inclusion up to childbirth)
  • Impact of different kind of MTCT prophylaxis during pregnancy on uninfected children(At childbirth, 1 month, 3 months, 6 months, 12 months and 18-24 months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (45)

Loading locations...

相似试验